|
MLF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.019580E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.528500E-02 |
| Normal-vs-Stage2 |
8.147800E-01 |
| Normal-vs-Stage3 |
2.037200E-04 |
| Normal-vs-Stage4 |
2.391800E-01 |
| Stage1-vs-Stage2 |
5.586000E-01 |
| Stage1-vs-Stage3 |
1.793140E-04 |
| Stage1-vs-Stage4 |
3.086400E-01 |
| Stage2-vs-Stage3 |
6.744100E-03 |
| Stage2-vs-Stage4 |
2.969000E-01 |
| Stage3-vs-Stage4 |
2.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.110300E-02 |
| Normal-vs-AfricanAmerican |
5.774200E-02 |
| Normal-vs-Asian |
2.663000E-01 |
| Caucasian-vs-AfricanAmerican |
6.750800E-01 |
| Caucasian-vs-Asian |
2.872200E-01 |
| AfricanAmerican-vs-Asian |
3.479800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.106200E-02 |
| Normal-vs-Female |
4.423200E-03 |
| Male-vs-Female |
1.051620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.493230E-01 |
| Normal-vs-Extreme_Weight |
3.566600E-01 |
| Normal-vs-Obese |
4.272500E-02 |
| Normal-vs-Extreme_Obese |
9.807000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.533600E-01 |
| Normal_Weight-vs-Obese |
8.071800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.985400E-01 |
| Extreme_Weight-vs-Obese |
3.445200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.321800E-01 |
| Obese-vs-Extreme_Obese |
3.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.061700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.719600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.211180E-01 |
| Normal-vs-Age(81-100Yrs) |
2.933800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.376100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.062300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.915570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.307400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.920400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.534200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.866500E-02 |
| Normal-VS-Type2 PRCC |
1.010820E-01 |
| Normal-VS-KIRP CIMP |
2.632000E-02 |
| Normal-VS-Unclassified PRCC |
1.456200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.399200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.676300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.972800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.451700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.883800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.741800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.363220E-01 |
| Normal-vs-N1 |
8.304400E-03 |
| Normal-vs-N2 |
5.880300E-02 |
| N0-vs-N1 |
1.090980E-01 |
| N0-vs-N2 |
1.389700E-02 |
| N1-vs-N2 |
1.226820E-01 |
|
|
